Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Revenues	$ 3,117,545	$ 0
Cost of Revenues	(1,328,076)	0
Net Revenues	1,789,469	0
Operating expenses:
Research and development	1,789,678	2,329,812
General and administrative	1,880,601	1,082,360
Total operating expenses	3,670,279	3,412,172
Loss from operations	(1,880,810)	(3,412,172)
Interest and other income, net	(176,397)	568,176
Net loss	(2,057,207)	(2,843,996)
Less: cumulative preferred dividends earned in the period	0	(477,358)
Net loss available for distribution to common stockholders	$ (2,057,207)	$ (3,321,354)
Net loss per share, basic and diluted	$ (0.06)	$ (0.69)
Weighted average shares outstanding, basic and diluted	35,778,032	4,839,871